Stem Cell Trial Seeks Longer Lives for Victims of Deadly ALS
January 8, 2014
Reuters / Powered by NewsLook.com
Researchers at Emory University in the United States are hoping to extend the lives of patients diagnosed with the deadly neuro-degenerative disease, Amyotrophic lateral sclerosis (ALS). ALS kills by destroying a patient's nervous system but in clinical trials, the scientists say injections of neural stem cells show promise in slowing the disease's progress. Ben Gruber reports.
Newsy (May 15, 2014) The mice were given human stem cells to test stem cell rejection. But instead of rejecting the human cells, the mice began to show positive reactions.
Video provided by ... watch video
Reuters (June 3, 2013) Researchers at the Harvard Stem Cell Institute have identified a blood protein they say can reverse the aging process in mouse hearts. After introducing the protein into the hearts of old mice, the ... watch video
AFP (Feb. 21, 2014) Indonesia institutes the world's biggest manta ray sanctuary covering millions of square kilometres as it seeks to protect the huge winged fish and draw more tourists to the sprawling archipelago. ... watch video
AFP (Nov. 29, 2015) As Hong Kong seeks to expand its international airport and with a major new bridge project under way, campaigners warn that the dwindling number of pink dolphins in the already busy surrounding ... watch video
July 29, 2016 In a study of more than 5,000 people, investigators have found that greater intake of nuts was associated with lower levels of biomarkers of inflammation, a finding that may help explain the health ... read more
July 29, 2016 They may be slimy, but they are a perfect environment for microorganisms: biofilms. Protected against external influences, here bacteria can grow undisturbed, and trigger diseases. Scientists are ... read more
July 29, 2016 Many deadly diseases that afflict humans were originally acquired through contact with animals. New research suggests that pathogens can also jump the species barrier to move from humans to animals. ... read more
June 29, 2016 A phase II clinical trial in people with amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, suggests that transplanting human stem cells into the spinal cord may be done safely. While ... read more
June 26, 2014 Scientists have demonstrated in fruit-flies that over-activity of the enzyme HDAC6 in the nerve ends exacerbates the symptoms of the neurodegenerative condition Amyotrophic Lateral Sclerosis (ALS / ... read more
Oct. 25, 2013 Researchers will soon begin phase IIa clinical trials of TDI-132, a drug that in animal models has shown promise in reducing the inflammation associated with Amyotrophic Lateral ... read more